Illustration: Kim Ryu for Endpoints News
February 28, 2023 07:25 AM ESTUpdated 05:28 PM
R&D
In Focus

Decades af­ter break­through, sci­en­tists still puz­zling over mR­NA de­liv­ery

Nicole DeFeudis

Editor

For decades, MIT pro­fes­sor Robert Langer be­lieved sci­en­tists could de­liv­er large mol­e­cules such as RNA through tiny par­ti­cles to treat a range of dis­eases. When …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times